{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:33:52Z","timestamp":1790685232104,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.therap.2017.01.010","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T16:01:59Z","timestamp":1487779319000},"page":"491-501","source":"Crossref","is-referenced-by-count":42,"title":["Dispositif pharmaco\u00e9pid\u00e9miologique de surveillance des substances psychoactives\u00a0: int\u00e9r\u00eats du programme national OPPIDUM du R\u00e9seau fran\u00e7ais d\u2019addictovigilance"],"prefix":"10.1016","volume":"72","author":[{"given":"Elisabeth","family":"Frauger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liselotte","family":"Pochard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Boucherie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Giocanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Daveluy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Gibaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sylvie","family":"Caous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Eiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Authier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reynald","family":"Le Boisselier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryl\u00e8ne","family":"Guerlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9milie","family":"Jouanjus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Lepelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Pizzoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Pain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.therap.2017.01.010_bib0260","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2515\/therapie\/2015009","article-title":"Signal identification in addictovigilance: the functioning of the French system","volume":"70","author":"Jouanjus","year":"2015","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.therap.2017.01.010_bib0265","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.therap.2016.05.001","article-title":"Twenty-five years of the French Addictovigilance Network (FAN)","volume":"71","author":"Micallef","year":"2016","journal-title":"Therapie"},{"issue":"3","key":"10.1016\/j.therap.2017.01.010_bib0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2515\/therapie\/2011045","article-title":"Post-marketing surveillance systems for psychoactive prescription drug abuse","volume":"66","author":"Nordmann","year":"2011","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2017.01.010_bib0275","first-page":"16","article-title":"DRAMES, nouvel outil pour conna\u00eetre les causes des d\u00e9c\u00e8s chez les toxicomanes\u00a0: bilan de cinq \u00e9tudes","volume":"1","author":"Boulos","year":"2008","journal-title":"Courrier Addict"},{"issue":"3","key":"10.1016\/j.therap.2017.01.010_bib0280","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00414-008-0291-x","article-title":"French Network of Centers for Evaluation and Information on Pharmacodependence. Chemical submission: results of 4-year French inquiry","volume":"123","author":"Djezzar","year":"2009","journal-title":"Int J Legal Med"},{"issue":"1","key":"10.1016\/j.therap.2017.01.010_bib0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s002280050246","article-title":"Falsified or forged medical prescriptions as an indicator of pharmacodependence: a pilot study","volume":"52","author":"Lapeyre-Mestre","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.therap.2017.01.010_bib0290","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00002018-200730030-00007","article-title":"Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey","volume":"30","author":"Boeuf","year":"2007","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.therap.2017.01.010_bib0295","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000356812","article-title":"A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions","volume":"20","author":"Lapeyre-Mestre","year":"2014","journal-title":"Eur Addict Res"},{"issue":"6","key":"10.1016\/j.therap.2017.01.010_bib0300","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/fcp.12024","article-title":"OPPIDUM surveillance program: 20\u00a0years of information on drug abuse in France","volume":"27","author":"Frauger","year":"2013","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.therap.2017.01.010_bib0305","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2515\/therapie:2007061","article-title":"Abus et d\u00e9pendances aux produits psychoactifs\u00a0: \u00e9tude de consommations \u00e0 travers l\u2019enqu\u00eate OPPIDUM 2004\u00a0du r\u00e9seau des CEIP","volume":"62","author":"Modelon","year":"2007","journal-title":"Therapie"},{"issue":"5","key":"10.1016\/j.therap.2017.01.010_bib0310","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2515\/therapie\/2012064","article-title":"Harm reduction centers (\u201cCAARUD\u201d): privileged places for warning signal detection in addictovigilance","volume":"67","author":"Moracchini","year":"2012","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.therap.2017.01.010_bib0315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2515\/therapie\/2012037","article-title":"General Practitioners\u2019 Contribution to Dependence Assessment: the OPEMA Programme","volume":"67","author":"Moracchini","year":"2012","journal-title":"Therapie"},{"issue":"3","key":"10.1016\/j.therap.2017.01.010_bib0320","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.therap.2016.02.001","article-title":"R\u00e9seau national des centres d\u2019addictovigilance. Characteristics of subjects under opiate maintenance treatment in primary care using the OPEMA data 2013","volume":"71","author":"Gentile","year":"2016","journal-title":"Therapie"},{"issue":"3","key":"10.1016\/j.therap.2017.01.010_bib0325","first-page":"90","article-title":"Consommation de cannabis en France\u00a0: bilan de l\u2019enqu\u00eate nationale OPPIDUM","volume":"23","author":"Micallef","year":"2009","journal-title":"Lettre Pharmacol"},{"issue":"2","key":"10.1016\/j.therap.2017.01.010_bib0330","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/pds.2263","article-title":"Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey","volume":"21","author":"Nordmann","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.therap.2017.01.010_bib0335","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2515\/therapie\/2012011","article-title":"National and regional market penetration rates of generic's high dosage buprenorphine: its evolution from 2006\u00a0to 2008, using reimbursed drug database","volume":"67","author":"Boczek","year":"2012","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.therap.2017.01.010_bib0340","first-page":"16","article-title":"Enqu\u00eate OPPIDUM\u00a0: consommation de m\u00e9thadone et de bupr\u00e9norphine haut dosage","volume":"11","author":"Nordmann","year":"2009","journal-title":"Courrier Addict"},{"key":"10.1016\/j.therap.2017.01.010_bib0345","series-title":"Relev\u00e9 de d\u00e9cision Commission des stup\u00e9fiants et psychotropes du 14\u00a0avril 2016","author":"ANSM","year":"2016"},{"issue":"10","key":"10.1016\/j.therap.2017.01.010_bib0350","first-page":"A5147","article-title":"Fatal poisoning among patients with drug addiction","volume":"62","author":"Simonsen","year":"2015","journal-title":"Dan Med J"},{"issue":"4","key":"10.1016\/j.therap.2017.01.010_bib0355","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s11524-015-9967-y","article-title":"Opioid overdose deaths in the city and county of San Francisco: prevalence, distribution, and disparities","volume":"92","author":"Visconti","year":"2015","journal-title":"J Urban Health"},{"issue":"1\u20133","key":"10.1016\/j.therap.2017.01.010_bib0360","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.forsciint.2012.11.010","article-title":"Methadone-related deaths in Norway","volume":"224","author":"Bernard","year":"2013","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.therap.2017.01.010_bib0365","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.forsciint.2015.08.017","article-title":"Methadone-related deaths. A ten year overview","volume":"257","author":"Vignali","year":"2015","journal-title":"Forensic Sci Int"},{"issue":"5","key":"10.1016\/j.therap.2017.01.010_bib0370","doi-asserted-by":"crossref","first-page":"e007629","DOI":"10.1136\/bmjopen-2015-007629","article-title":"The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales","volume":"5","author":"Marteau","year":"2015","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.therap.2017.01.010_bib0375","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1472-8206.2011.00950.x","article-title":"Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey","volume":"26","author":"Frauger","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.therap.2017.01.010_bib0380","article-title":"Which psychoactive substances are found in used syringes?","author":"Nordmann","year":"2016","journal-title":"Therapie"},{"issue":"5","key":"10.1016\/j.therap.2017.01.010_bib0385","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/00015550510033192","article-title":"Cutaneous complications of direct intra-arterial injections in drug addicts","volume":"85","author":"Del Giudice","year":"2005","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.therap.2017.01.010_bib0390","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.revmed.2009.10.433","article-title":"Complications infectieuses induites par le m\u00e9susage de la bupr\u00e9norphine haut dosage (Subutex\u00ae)\u00a0: analyse r\u00e9trospective de 42\u00a0observations","volume":"31","author":"Grau","year":"2010","journal-title":"Rev Med Interne"},{"issue":"6","key":"10.1016\/j.therap.2017.01.010_bib0395","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.therap.2016.07.001","article-title":"Medical complications of psychoactive substances with abuse risks: detection and assessment by the network of French addictovigilance centres","volume":"71","author":"Peyri\u00e8re","year":"2016","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.therap.2017.01.010_bib0400","first-page":"15","article-title":"\u00c9tude des pratiques d\u2019injection intraveineuse et autres d\u00e9tournements du m\u00e9thylph\u00e9nidate (r\u00e9gion Paca-Corse)","volume":"13","author":"Frauger","year":"2011","journal-title":"Courrier Addict"},{"issue":"6","key":"10.1016\/j.therap.2017.01.010_bib0405","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2515\/therapie\/2008063","article-title":"Isch\u00e9mie digitale apr\u00e8s injection d\u2019un comprim\u00e9 pil\u00e9 de zolpidem, am\u00e9lioration tardive par l\u2019iloprost","volume":"63","author":"Boucher","year":"2008","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.therap.2017.01.010_bib0410","first-page":"26","article-title":"Isch\u00e9mie aigu\u00eb irr\u00e9versible de la main apr\u00e8s injection intra-art\u00e9rielle de zolpidem","volume":"14","author":"Bertaut","year":"2012","journal-title":"Courrier Addict"},{"issue":"6","key":"10.1016\/j.therap.2017.01.010_bib0415","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2515\/therapie\/2011069","article-title":"Severe distal ischemic syndrome after buprenorphine volunteer intra-arterial injection","volume":"66","author":"Glaizal","year":"2011","journal-title":"Therapie"},{"issue":"12","key":"10.1016\/j.therap.2017.01.010_bib0420","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1056\/NEJMicm050711","article-title":"Images in clinical medicine. Talc retinopathy","volume":"354","author":"El-Jabali","year":"2006","journal-title":"N Engl J Med"},{"issue":"1\u20133","key":"10.1016\/j.therap.2017.01.010_bib0425","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.forsciint.2009.12.066","article-title":"Widespread pulmonary granulomatosis following long time intravenous drug abuse--a case report","volume":"197","author":"Dettmeyer","year":"2010","journal-title":"Forensic Sci Int"},{"issue":"12","key":"10.1016\/j.therap.2017.01.010_bib0430","doi-asserted-by":"crossref","first-page":"e113991","DOI":"10.1371\/journal.pone.0113991","article-title":"Crushed and injected buprenorphine tablets: characteristics of princeps and generic solutions","volume":"9","author":"Bouqui\u00e9","year":"2014","journal-title":"Plos One"},{"issue":"2","key":"10.1016\/j.therap.2017.01.010_bib0435","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00228-014-1783-x","article-title":"Detection of signals of abuse and dependence applying disproportionality analysis","volume":"71","author":"Pauly","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.therap.2017.01.010_bib0440","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000346179","article-title":"Slow-release oral morphine sulfate abuse: results of the postmarketing surveillance systems for psychoactive prescription drug abuse in France","volume":"19","author":"Peyriere","year":"2013","journal-title":"Eur Addict Res"},{"issue":"2","key":"10.1016\/j.therap.2017.01.010_bib0445","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2515\/therapie\/2015006","article-title":"Drug abuse monitoring: which pharmacoepidemiological resources at the European level?","volume":"70","author":"Lapeyre-Mestre","year":"2015","journal-title":"Therapie"},{"issue":"6","key":"10.1016\/j.therap.2017.01.010_bib0450","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.therap.2016.04.006","article-title":"Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse history","volume":"71","author":"Driot","year":"2016","journal-title":"Therapie"},{"issue":"9","key":"10.1016\/j.therap.2017.01.010_bib0455","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40261-016-0421-z","article-title":"Disproportionality analysis for the assessment of abuse and dependence potential of pregabalin in the French pharmacovigilance database","volume":"36","author":"Bossard","year":"2016","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.therap.2017.01.010_bib0460","series-title":"Compte-rendu Commission des stup\u00e9fiants et psychotropes du 25\u00a0juin 2015","author":"ANSM","year":"2015"},{"issue":"3","key":"10.1016\/j.therap.2017.01.010_bib0465","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000355268","article-title":"Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers","volume":"20","author":"Baird","year":"2014","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.therap.2017.01.010_bib0470","article-title":"R\u00e9seau des Centres d\u2019addictovigilance. Abuse liability of quetiapine (Xeroquel\u00ae)","author":"Peyri\u00e8re","year":"2015","journal-title":"Therapie"},{"issue":"1","key":"10.1016\/j.therap.2017.01.010_bib0475","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/fcp.12233","article-title":"Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM survey","volume":"31","author":"Daveluy","year":"2017","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.therap.2017.01.010_bib0480","first-page":"89","article-title":"Doctor shopping reveals geographical variations in opioid abuse","volume":"16","author":"Nordmann","year":"2013","journal-title":"Pain Physician"},{"issue":"7","key":"10.1016\/j.therap.2017.01.010_bib0485","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/pds.892","article-title":"Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database","volume":"13","author":"Pradel","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.therap.2017.01.010_bib0490","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2165\/11587640-000000000-00000","article-title":"Patterns of methylphenidate use and assessment of its abuse and diversion in two French administrative areas using a proxy of deviant behaviour determined from a reimbursement database: main trends from 2005\u00a0to 2008","volume":"25","author":"Frauger","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.therap.2017.01.010_bib0495","article-title":"Les personnes accueillies dans les CSAPA","volume":"110","author":"OFDT","year":"2016","journal-title":"Tendances"},{"issue":"Suppl. 1","key":"10.1016\/j.therap.2017.01.010_bib0500","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.drugalcdep.2009.08.011","article-title":"Monitoring risk: post marketing surveillance and signal detection","volume":"105","author":"Dart","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"RR-5","key":"10.1016\/j.therap.2017.01.010_bib0505","first-page":"1","article-title":"Framework for evaluating public health surveillance systems for early detection of outbreaks: recommendations from the CDC working group","volume":"53","author":"Buehler","year":"2004","journal-title":"MMWR Recomm Rep"},{"issue":"1\u20132","key":"10.1016\/j.therap.2017.01.010_bib0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2012.03.009","article-title":"Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France","volume":"126","author":"Pauly","year":"2012","journal-title":"Drug Alcohol Depend"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595717300422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595717300422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T15:45:10Z","timestamp":1750002310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595717300422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0040595717300422"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2017.01.010","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}